YPB Group (ASX:YPB) - CEO, John Houston
CEO, John Houston
Source: Yahoo Finance
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Product authenticator YPB Group (YPB) has launched a patent application in China for one of its disinfectant inventions
  • The product essentially works by adding luminescent tracer to the disinfectant, allowing the user to see if an area has been disinfected
  • It also allows the user to tell when an area has been disinfected and whether or not re-sterilisation is needed
  • The company filed the patent with China’s relevant regulatory authority on December 31, 2020
  • Since the patent announcement, YPB’s share price has jumped 25 per cent, with shares trading at 0.3 cents each at the end of Monday’s session

YPB Group (YPB) has launched a patent application in China for one of its disinfectant inventions.

The invention essentially works by adding luminescent tracer to disinfectant, allowing the user to see if an area has been cleaned.

The product authentication business said it also allows the user to tell when an area has been disinfected and whether or not re-sterilisation is needed.

“The invention is universal in nature and when combined with conventionally used disinfection solutions, can quickly determine whether daily disinfection is in place, disinfection time and the need for any re-sterilisation,” the group stated.

YPB filed the patent application with China’s relevant regulatory authority on December 31, 2020.

It hasn’t stated when it expects the application to be processed, however, the company will provide an update to shareholders as it progresses.

Shares in YPB Group are trading up 25 per cent in response to the patent announcement, trading at 0.3 cents each at the close of market on Monday.

YPB by the numbers
More From The Market Online

Cettire turbulent on $191M revenue, but no word on customs scandal

Cettire shares spiked upwards right out the gate on Friday on the same day the company…

Vitura joint venture prescribes shrooms for therapeutic use in Australian-first

In an Australian-first pharmaceutical achievement, Vitura Health Limited has announced the first ever shipment of 'shrooms'…

23% profit jump for NZ dairy co-op Fonterra

New Zealand dairy cooperative Fonterra has raised its profits 23 percent to NZ$674 million in the…

The Calmer Co’s FijiKava now at USA’s Walmart

Not long after hitting the shelves at Coles, Calmer Co's Fiji Kava products have hit the…